Sandi Jiongco
Family · Naperville, ILNPI 1225428741
Payments from drug & device makers
Across 100 payments — averaging $48.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$3K
- Kerecis Limited$707
- Smith+Nephew$285
- Misonix Inc$247
- Bioventus LLC$176
- Mimedx Group, Inc.$173
- plus $737 from 14 others
What the payments were for
- Food & beverage$2,34448%
- Other$2,50152%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 4 | $2,521 |
| Kerecis Limited | 7 | $707 |
| Smith+Nephew | 10 | $285 |
| Misonix Inc | 25 | $247 |
| Bioventus LLC | 13 | $176 |
| Mimedx Group, Inc. | 6 | $173 |
| Tactile Systems Technology Inc | 8 | $136 |
| Paratek Pharmaceuticals, Inc. | 7 | $135 |
| Surgenex LLC | 3 | $94 |
| Acera Surgical, Inc. | 3 | $66 |
| Organogenesis Inc. | 3 | $66 |
| ETS Wound Care LLC | 2 | $41 |
| Omeza LLC | 2 | $36 |
| KCI USA, Inc. | 1 | $31 |
| Molnlycke Health Care US, LLC | 1 | $29 |
| OVIK Health, LLC | 1 | $28 |
| Next Science LLC | 1 | $21 |
| Cashflow Solutions, LLC | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Convatec Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,845 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 59 | $2,425 |
| Doxycycline Hyclate | 17 | $148 |
| Ciprofloxacin Hcl | 19 | $92 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $77 |
Paid to pharmacies, not to this prescriber.
Other family in Naperville
- Erin SieberNaperville$334K
- Rachel SulfridgeNaperville$13K
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.